why choose us

First received: February 28, 2023

Clinical Trial: Carfilzomib, Oral Cyclophosphamide, and Dexamethasone for RRMM

Study Status: NOT_YET_RECRUITING

Recruit Status: NOT_YET_RECRUITING

Condition: Multiple Myeloma in Relapse

Study Type: INTERVENTIONAL


Official Title: A Phase II Study of Carfilzomib, Oral Cyclophosphamide, and Dexamethasone for Relapsed and/or Refractory Multiple Myeloma

Brief Summary: This study aims to study the efficacy and safety of oral cyclophosphamide in addition to carfilzomib and dexamethadone for RRMM patients who have been previously exposed to lenalidomide combination therapies.

Read more